Overall impact
B (61)

Commentary

AddLife is a strong overall performer. With a 'B' rating of 61.1 for overall impact (65th percentile compared to all companies), AddLife ranks 53rd out of 76 industry peers, behind IMAC, Enzo Biochem, Invitae and 49 others, and ahead of Ortho Clinical Diagnostics, Dexcom, Perkinelmer and 20 others. On top material causes for AddLife's industry (Healthcare Software & Services), AddLife performs well in Improved Mental Health (89.1 score) and performs poorly in Quality Lifelong Education (39.3 score).
Impact
Cause 0REZ.L
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company

AddLife

Employees
2,360
Sector
Health Care
Industry
Biotechnology
Sub-industry
Biotechnology
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Sweden
Share classes
ADDLY
ADR
0REZ.L
Description
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis equipment. It offers products and solutions, including instruments and equipment, plastic consumables, cell biology, reagents, general lab, and other instruments used to diagnose diseases and conduct research. The Medtech segment provides medical device products for orthopedic, hospital consumables, critical care, endoscopy, wound care, healthcare it, ophthalmology, home adaptation, aid supply & equipment, welfare technology, and construction, as well as welfare technology and assistive technology for the elderly and people with disabilities. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, and rest of world. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
Material causes
Ethos considers the following causes material for AddLife, based on its industry sub-industry Biotechnology. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.